Bausch Lomb Ownership

BLCO Stock  USD 15.75  0.26  1.68%   
Bausch Lomb holds a total of 352.47 Million outstanding shares. Bausch Lomb Corp shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 88.41 percent of Bausch Lomb Corp outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Bausch Lomb in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Bausch Lomb, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Lomb Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Bausch Stock Ownership Analysis

About 88.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.84. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bausch Lomb Corp has Price/Earnings To Growth (PEG) ratio of 0.7. The entity recorded a loss per share of 0.9. The firm had not issued any dividends in recent years. Bausch Lomb Corporation operates as an eye health company worldwide. The company was founded in 1853 and is headquartered in Vaughan, Canada. Bausch Lomb operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 12500 people. For more info on Bausch Lomb Corp please contact Brenton JD at 905-695-7700 or go to https://www.bausch.com.
Besides selling stocks to institutional investors, Bausch Lomb also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Bausch Lomb's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Bausch Lomb's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Bausch Lomb Quarterly Liabilities And Stockholders Equity

13.47 Billion

Bausch Lomb Insider Trades History

About 88.0% of Bausch Lomb Corp are currently held by insiders. Unlike Bausch Lomb's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Bausch Lomb's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Bausch Lomb's insider trades
 
Covid

Bausch Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Bausch Lomb is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bausch Lomb Corp backward and forwards among themselves. Bausch Lomb's institutional investor refers to the entity that pools money to purchase Bausch Lomb's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Laurion Capital Management Lp2024-12-31
M
Empyrean Capital Partners, Lp2024-12-31
931 K
Citadel Advisors Llc2024-12-31
883.6 K
Canada Pension Plan Investment Board2024-12-31
851.7 K
Ratan Capital Management Lp2024-12-31
811.4 K
T. Rowe Price Associates, Inc.2024-12-31
781.9 K
Diameter Capital Partners Lp2024-12-31
701.4 K
Caspian Capital Partners, L.p.2024-09-30
650 K
Clearline Capital Lp2024-12-31
646.6 K
Icahn Carl C2024-12-31
3.5 M
Maple Rock Capital Partners, Inc.2024-12-31
3.2 M
Note, although Bausch Lomb's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Bausch Lomb Corp Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Bausch Lomb insiders, such as employees or executives, is commonly permitted as long as it does not rely on Bausch Lomb's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Bausch Lomb insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Bausch Lomb Outstanding Bonds

Bausch Lomb issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Bausch Lomb Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Bausch bonds can be classified according to their maturity, which is the date when Bausch Lomb Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Bausch Lomb Corporate Filings

F4
3rd of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
19th of February 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
4th of October 2024
Other Reports
ViewVerify
10Q
1st of August 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify

Pair Trading with Bausch Lomb

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bausch Lomb position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Lomb will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bausch Stock

  0.81EYEN EyenoviaPairCorr

Moving against Bausch Stock

  0.88JNJ Johnson JohnsonPairCorr
  0.87NVRO Nevro CorpPairCorr
  0.85T ATT Inc Earnings Call This WeekPairCorr
  0.79CMRX Chimerix Sell-off TrendPairCorr
  0.74VZ Verizon CommunicationsPairCorr
The ability to find closely correlated positions to Bausch Lomb could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bausch Lomb when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bausch Lomb - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bausch Lomb Corp to buy it.
The correlation of Bausch Lomb is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bausch Lomb moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bausch Lomb Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bausch Lomb can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Bausch Lomb Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Lomb's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Lomb Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Lomb Corp Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Lomb Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Lomb. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Lomb listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.89)
Earnings Share
(0.90)
Revenue Per Share
13.619
Quarterly Revenue Growth
0.091
Return On Assets
0.0096
The market value of Bausch Lomb Corp is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Lomb's value that differs from its market value or its book value, called intrinsic value, which is Bausch Lomb's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Lomb's market value can be influenced by many factors that don't directly affect Bausch Lomb's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Lomb's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Lomb is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Lomb's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.